Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 2 of 206 pages  < 1 2 3 4 >  Last ›

Fisher JA, Kalbaugh CA
United States Private-Sector Physicians and Pharmaceutical Contract Research: A Qualitative Study
PLoS Med 2012 July 24;9:(7):

Saying 'no thanks' to the pharmaceutical industry's undue influence
Prescrire 2012 July 23;

Sharma H
Pharma firms funding foreign trips for doctors
IBN Live 2012 July 18

ACTA is dead, long live ACTA? ACTA-like measures still in EU IP policies
HAI Europe 2012 July 16

‘Sponsored’ doctors under scanner
The New Indian Express 2012 July 11

Glekin J
India's pro-poor policy may be getting healthier
Reuters Breakingviews 2012 July 5

Glaxo to pay $3 bn for largest health fraud in US
The Washington Post 2012 July 3

GlaxoSmithKline to pay $3bn in US drug fraud scandal
BBC News 2012 July 2

Karlin M
Big Pharma Drug Company Gets Fined 3 Billion Dollars for Marketing Abuse of Drugs, But No Criminal Charges
The Buzzflash Blog 2012 July 2

Ray K
Drug companies fleecing consumers: Study
The Deccan Herald 2012 Jun 15

Kaplan WA, Ritz LS, Vitello M, Wirtz VJ
Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000-2010
Health Policy 2012 Jun 13;

Weissman R, So A
Generating Antibiotic Incentives Now: GAIN Or Just Greed
Citizen Vox 2012 Jun 12

Dabade G
When drug regulators play with people’s lives
The Deccan Herald 2012 May 22

Godlee F
Research misconduct is widespread and harms patients
BMJ 2012 May 1;344:

Big Pharma spends over €40 million per year lobbying in the EU, dwarfing public health NGOs
HAI Europe 2012 Mar 28

Silverman E
Pharma Execs Admit: ‘Our Model Is Broken’
Pharmalot 2012 Mar 21

Dunlevy S
Australian Big Pharma to derail gravy train Ken Harvey
The Australian 2012 Mar 19

O'Brien M
'Unethical': NHMRC to reveal stance on homeopathy
Medical Observer 2012 Mar 14

Bajaj V, Pollack A
If Novartis wins, prices of drugs could sky-rocket
The Deccan Herald 2012 Mar 8

Reid-Henry S
Novartis vs India: the showdown approaches
New Internationalist Blog 2012 Feb 28

Metherell M
Hunt for the truth behind diet pill
The Sydney Morning Herald 2012 Feb 18

Baloch F
Spurious drugs case: Pharma association’s acting chief blasts industry, regulator
The Express Tribune 2012 Feb 17

Imprensa RP
Anvisa não pode mais vetar publicidade de medicamentos, diz Justiça
Portal Imprensa 2012 Feb 3

Pickett FA
Misrepresentation of Scientific Studies Misleads Professional Caregivers
Dentition 2012 Feb;1:(1):14-19

Brody H
Opinion: Celebrities Pushing Drugs?
The Scientist 2012 Jan 30

Cohen D
Deborah Cohen: Roche responds
BMJ Group Blogs 2012 Jan 27

Bosch X, Esfandiari B, McHenry L
Challenging Medical Ghostwriting in US Courts
PLoS Med 2012 Jan 24;9:(1):

Key Opinion Leaders Who Lend Their Names to Ghostwritten Medical Articles Should Be Held Legally Liable, Article States
Baum, Hedlund, Aristei & Goldman 2012 Jan 24

Collins G
Call to axe starter packs
6minutes 2012 Jan 23

Alexander J
Health ministry asks state drug controllers to closely monitor misleading ads on vitamins, creams
Pharmabiz 2012 Jan 18

Laurance J
Implant danger extends to all medical devices
The Independent 2012 Jan 18

Pear R
U.S. to Force Drug Firms to Report Money Paid to Doctors
The New York Times 2012 Jan 16

Dabade G
With 100% FDI in pharma, medicines may soon cost more
The Deccan Herald 2012 Jan 15

Khor M
TWN Info Service on Intellectual Property Issues
Third World Network 2012 Jan 14

Voreacos D, Cronin Fisk M, Feeley J
J&J Marketed Risperdal for Kids After FDA Warnings, Jurors Told
Bloomberg 2012 Jan 14

Braillon A
Drug industry is now biggest defrauder of US government
BMJ 2012 Jan 10;344:

Christensen M, Knop FK
The unobtainable placebo: control of independent clinical research by industry?
The Lancet 2012 Jan 7;379:(9810):30

Shankar PR, Singh KK, Piryani RM
Knowledge, attitude and skills before and after a module on pharmaceutical promotion in a Nepalese medical school
BMC Research Notes 2012 Jan 6;5:(8):

Fiddamen B
APA Use Restraints on Blogger
Seroxat Sufferers: Stand Up and Be Counted 2012 Jan 4

Lehman R, Loder E
Missing clinical trial data
BMJ 2012 Jan 3;344:

Cardenal Taján J
GSK fined after over vaccine trials; 14 babies reported dead
Buenos Aires Herald 2012 Jan 3

Moynihan R
Kissing goodbye to key opinion leaders
Medical Journal of Australia 2012;196:(11):671

Lexchin J, Vitry A
Should the C in CME Stand for Commercial?
Southern Med Review 2012;5:(1):3-5

Grills NJ
The ethics of industry sponsorship of charities
MJA 2012;197:(3):139

Wolfe SM
The seven-year rule for safer prescribing
Aust Prescr 2012;35:(5):138-9

Puliyel J
Compensation for Victims of Clinical Trials: A Discussion on How Current Indian Rules and Guidelines are Hurting India
Journal of Clinical and Diagnositic Research 2012;

Conflicts of Interest in Medicine
Current Medicine.TV 2011 Dec 28

Dal-Ré R, Moher D, Gluud C, Treweek S, Demotes-Mainard J, Carné X
Disclosure of Investigators' Recruitment Performance in Multicenter Clinical Trials: A Further Step for Research Transparency
PLoS Med 2011 Dec 27;8:(12):

Snowbeck C
U, Mayo cultivate close ties to drug firms
Twin Cities 2011 Dec 26

Lenzer J
Disease Creep: How we're fooled into using more medicine than we need.
The New Health Dialogue 2011 Dec 22

Brauner Barcellos G
Congressos, Jornadas, Simpósios...
Saude Web 2011 Dec 20

Social media in the 16th Century: How Luther went viral
The Economist 2011 Dec 17

González-Bailón S, Borge-Holthoefer J, Rivero A, Moreno Y
The Dynamics of Protest Recruitment through an Online Network
Sci Rep. 2011 Dec 15;1:197

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: Drug Safety Communication - Use During Pregnancy and Potential Risk of Persistent Pulmonary Hypertension of the Newborn 2011 Dec 14

What's in store for the TGA
Pharmacy Daily 2011 Dec 12

Sayare S
Scandal Over Mediator, a French Weight-Loss Drug, Prompts Calls for Wide Changes
The New York Times 2011 Dec 12 ug-mediator.html

Carlat D
Conflict of Interest--From a Patient's Perspective
Carlat Psychiatry Blog 2011 Dec 12

Jack A, Burgis T
Pfizer calls WikiLeaks cable ‘preposterous’
The Finanical Times 2010 Dec 11

Mares P
Health watchdog gets a few more teeth, but still lacks bite
National Interest : ABC Radio National 2011 Dec 90

Sweet M
The backlash against universities offering complementary medicine courses
Croakey 2011 Dec 9

Harvey K
TGA all bark no bite as Labor botches response to a series of reviews
The Conversation 2011 Dec 8

Jewett C
Top antipsychotic prescribers also drug promoters
California Watch 2010 Dec 6

Estratégias de marketing da indústria farmacêutica e a venda de medicamentos
Institudo Salas 2011 Dec 2

Harmon K
Patients Get More Unnecessary Scans from Doctors Who Own Equipment
Scientific American 2011 Nov 30

Cláudio Correia L
Viés, Acaso e Demissão
Medicina Baseada em Evidencias 2011 Nov 27

Cook J, Lewandowsky S
The Debunking Handbook: now freely available for download
Skeptical Science 2011 Nov 27

Matwankar A
Maharashtra FDA to act against advertisements on drugs and medical devices
Pharmabiz 2011 Nov 25

Ramshaw E, Murphy R
Payments to Doctors by Pharmaceutical Companies Raise Issues of Conflicts
The New York Times 2011 Nov 24

Dermatology Residents Believe Interactions with Industry are Ethical
CME Coalition 2011 Nov 22

Teuto A
Indústria Farmacêutica foca nas ações em congressos médicos
Dr Teuto 2011 Nov 21ústria+Farmacêutica+foca+nas+ações+em+congressos+médicos

1 Boring Old Man
a walk on the wrong side side of the street?…
1 Boring Old Man 2011 Nov 20

Uken C
Payment debate: Health care workers defend their payments from drug companies
Billings Gazette 2011 Nov 20

Auron M
What to believe?
Meds-Peds Hospital Medicine 2011 Nov 18

Luthra S
Prof’s study linked to child suicide
The Brown Daily Herald 2011 Nov 17

Erasmus MC dismisses professor
Erasmus MC 2011 Nov 17

Holtedahl R
Orthopaedic surgeons in the pocket of the industry
Tidsskr Nor Legeforen 2011 Nov 15;

A importância do marketing e do propagandista na indústria farmacêutica
Artigonal 2011 Nov 8

Aubrey A
Second Thoughts On Medicines For Babies Who Spit Up
npr 2011 Nov 70

Serafino P, Kitamura M
Glaxo to Pay $3 Billion to Settle U.S. Cases on Sales, Marketing, Avandia
Bloomberg 2011 Nov 4

Righetti S
Um em cada cinco estudos médicos tem autor indevido 2011 Nov 4

GlaxoSmithKline reaches agreement in principle to resolve multiple investigations with US Government
GlaxoSmithKline 2011 Nov 3

Wilson D
Glaxo Settles Cases With U.S. for $3 Billion
The New York Times 2011 Nov 3

Baum M, Thornton H, Gøtzsche PC, Bewley S, Jørgensen KJ, Barratt A, Ross N, Woloshin S, Schwartz L, Musiello T, Blennerhassett M, Napoli M, Baines CJ, Vaidya JS, Williams N, Havercroft D, Zahl PH, Retsky M, Kaplan RM, Dixon-Woods M, Berry DA, Isaacson K,
Breast cancer awareness month. Still awaiting screening facts.
BMJ. 2010 Nov 2;341:c6152. doi: 10.1136/bmj.c6152

Hanrahan C
Dismay at drug company push for govt subsidy
Medical Observer 2011 Nov 1

Wilson M, Epstein M
A sunshine act for Europe: The dark side of the sun
BMJ 2011 Nov 1;343:

Ariely D
A Dinner with Drug Reps
Dan Ariely 2011 Nov 1

Misleading ads by drug firms must be checked
The New Indian Express 2011 Oct 29

Figueiredo Gomes B
Traição Disfarçada na Saúde
Divagando em Saúde 2011 Oct 25

Williams DE
Xigris withdrawal highlights conflict of interest problems
Health Business Blog 2011 Oct 25

Monbiot G
Advertising is a poison that demeans even love – and we're hooked on it
The Guardian 2011 Oct 24

Hagan K
Ethical fears over Pfizer deal with pharmacists
The Sydney Morning Herald 2011 Oct 20

Collucci C
Droga psiquiátrica é veneno para crianças, diz médica 2011 Oct 18

Figueiredo Gomes B
A Depilação do Tatá
Divagando em Saúde... 2011 Oct 18

Dunlevy S
Drug companies pay doctors to spruik products
The Australian 2011 Oct 17

Doctors accepting payments from drug companies
ABC News 2011 Oct 16

Moynihan R
A noble cause
Background Briefing : ABC Radio National 2011 Oct 160

Srinivasan S
Dangers of FDI in pharma
Business Line 2011 Oct 14

Ornstein C
Should you care about those conflicts of interest?
Healthy Buzz 2011 Oct 14

Redrafted proposals still contain loopholes for disguised advertising
HAI Europe 2011 Oct 11

Avorn J, Choudhry NK
Controversies in Cardiovascular Medicine
American Heart Association 2011 Oct 11;

Page 2 of 206 pages  < 1 2 3 4 >  Last ›


  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Click to Register

(read more)

Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.

Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909